Breast Biopsy Market Set To Reach worth $728.8 Million by 2020

The report ““Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020”, the global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.

Browse 75 market data tables and 66 figures spread through 152 pages and in-depth TOC on “Breast Biopsy Market"http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.htmlEarly buyers will receive 10% customization on this report.

This report segments the breast biopsy market on the basis of product, guidance system, type, and region.

Based on type, the breast biopsy market is categorized into the needle and open surgical breast biopsy segments. The needle breast biopsy market is further sub segmented into core-needle biopsy (CNB), fine-needle aspiration biopsy (FNAB) and vacuum-assisted biopsy (VAB) market. Among these, VAB is expected to be the fastest-growing segment during the forecast period. Market growth can be attributed to the growing demand for less-invasive breast biopsies worldwide.

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=189011805

By guidance system, the market is segmented into mammography, ultrasound, MRI, and others (PET and thermography). The mammography-guided breast biopsy segment accounted for the largest share of the breast biopsy market in 2015 owing to its ease of use and reliability.

On the basis of product, the market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The guidance systems segment is expected to be the fastest-growing segment during the forecast period owing to the increase in demand for needles.

North America and Europe are established markets for breast biopsy. However, developing regions in Asia-Pacific (China and India) are expected to witness a higher growth rate in the forecast period. The growing purchasing power of the middle class and increasing awareness about breast cancer screening in different countries are the major factors fueling the growth of the breast biopsy market in Asia-Pacific. A number of companies are investing in these countries to gain the competitive edge as well as enhance their profitability in the market.

Talk To Our Research Analysts for More Information:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=189011805

Major factors fueling market growth are the rising incidences of breast cancer among women and increase in breast cancer screening programs in different countries. In addition to this, the increase in reimbursement rates in U.S. for image-guided biopsy and the growing demand for less-invasive breast biopsy are propelling the growth of the market.

Major players operating in the breast biopsy market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), and Hologic Inc. (U.S.).

Browse Related Reports:Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020.http://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics-market-186559121.html

Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019.http://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html

About MarketsandMarkets:MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:Mr. RohanUnit No. 802, 8th Floor, Tower - 7, Magarpatta City SEZ,Hadapsar, Pune – 411013, Maharashtra, India.Tel: +1-888-6006-441.Email: sales@marketsandmarkets.comVisit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devicesConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets